More targets, more pathways and more clues for mutant p53.
about
Atypical Rho GTPases of the RhoBTB Subfamily: Roles in Vesicle Trafficking and TumorigenesisHsp90-dependent assembly of the DBC2/RhoBTB2-Cullin3 E3-ligase complexComparative expression study of the endo-G protein coupled receptor (GPCR) repertoire in human glioblastoma cancer stem-like cells, U87-MG cells and non malignant cells of neural origin unveils new potential therapeutic targetsDual-faced SH3BGRL: oncogenic in mice, tumor suppressive in humansTranscriptome profiling of CTLs regulated by rapamycin using RNA-SeqPrimed for cancer: Li Fraumeni Syndrome and the pre-cancerous nicheMutant p53 expression in fallopian tube epithelium drives cell migrationSpontaneous Transformation of Murine Oviductal Epithelial Cells: A Model System to Investigate the Onset of Fallopian-Derived Tumors.Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis.Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth.Aberrant Epigenetic Modifications of LPHN2 Function as a Potential Cisplatin-Specific Biomarker for Human Gastrointestinal Cancer.Gain-of-function miRNA signature by mutant p53 associates with poor cancer outcomeCadherin-6 type 2, K-cadherin (CDH6) is regulated by mutant p53 in the fallopian tube but is not expressed in the ovarian surface.Does not hUTP14a promoter form a regulation feedback loop with P53?TP53 mutants in the tower of babel of cancer progression.Preferred binding of gain-of-function mutant p53 to bidirectional promoters with coordinated binding of ETS1 and GABPA to multiple binding sites.Tumor suppressor FOXO3 regulates ribonucleotide reductase subunit RRM2B and impacts on survival of cancer patients.Cysteine-conjugated metabolites of ginger components, shogaols, induce apoptosis through oxidative stress-mediated p53 pathway in human colon cancer cells.Localisation of keratin K78 in the basal layer and first suprabasal layers of stratified epithelia completes expression catalogue of type II keratins and provides new insights into sequential keratin expression.Multiple genes identified as targets for 20q13.12-13.33 gain contributing to unfavorable clinical outcomes in patients with hepatocellular carcinoma.Pharmacogenetics of response to neoadjuvant paclitaxel treatment for locally advanced breast cancer.Expression of SESN1, UHRF1BP1, and miR-377-3p as prognostic markers in mutated TP53 squamous cell carcinoma of the head and neck.A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts.ARID3B expression in primary breast cancers and breast cancer-derived cell lines.p53 and metabolism: from mechanism to therapeutics.Salivary metabolite profiling distinguishes patients with oral cavity squamous cell carcinoma from normal controls
P2860
Q26744456-254FCD51-5AF2-4C98-9C6D-2B1AE07078CAQ28540619-A1072226-D54C-4560-A7CF-D8BF2E80DC3DQ28541360-4D55278C-1A8F-4196-96BA-094413BF28EEQ30009087-0BFC2F0C-E60A-4EE1-8601-A8AB6B5E848EQ34345253-3DE32EF1-0E50-4EB5-B227-47B1091E778FQ35717532-662DB196-E842-459A-9287-7E655180C9F8Q35855276-8A1DA40E-B275-4ABB-B00B-38BB85402EE0Q35859678-196C822E-D710-409C-B369-2308BE9E3F6CQ36050759-A7CCDD42-048B-4EBD-AD7B-FCCCC5BF9E60Q36056465-5C4EAE44-224A-46F5-975C-A522F0075055Q36832161-D53425F5-8097-4E20-8B9E-937C0A068B19Q36998156-653F645E-0B16-45D4-B954-311AA0E37B50Q37688456-AF2BBFFB-B29F-45CA-B9C3-C6B4EC97ED13Q37725422-F5DDF9B5-8A95-47B1-9609-C0072F534F85Q38180665-4B80A9BB-B204-4A55-A6F3-491566434B8CQ38457645-17ADC5AC-5776-472A-90C3-EA9EBEC97610Q38982791-B3C9C428-2666-4B06-B198-072F1B34D349Q39939944-144EC46C-2FED-4F95-9B97-6C885A37F6F7Q40572620-43BD953C-EFE4-4870-ABDC-60C1C3FB5FCEQ41676450-E84AF4F1-9BBE-49E9-9920-6F7E01C66F09Q47241273-AE8C4702-E385-4710-80AC-5E6615FC02B2Q50197086-ABF4FFDB-1285-4F19-80E3-E6EC297898A5Q52722381-E34C0AB4-73C8-4372-B956-FEBE1CF747CAQ54194894-5B83B5C2-43E1-431B-A347-C9F24CBA9F76Q55002919-F2A2CA4F-785E-49FF-9BD0-A45B6C2B04D8Q58713199-BDCC9117-F569-4D22-9E19-167539F40BF7
P2860
More targets, more pathways and more clues for mutant p53.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
More targets, more pathways and more clues for mutant p53.
@ast
More targets, more pathways and more clues for mutant p53.
@en
type
label
More targets, more pathways and more clues for mutant p53.
@ast
More targets, more pathways and more clues for mutant p53.
@en
prefLabel
More targets, more pathways and more clues for mutant p53.
@ast
More targets, more pathways and more clues for mutant p53.
@en
P2093
P2860
P356
P1433
P1476
More targets, more pathways and more clues for mutant p53.
@en
P2093
P2860
P2888
P356
10.1038/ONCSIS.2013.15
P577
2013-07-01T00:00:00Z
P5875
P6179
1041825613